Lessons from the Pacific programme to eliminate lymphatic filariasis: A case study of 5 countries

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Huppatz, Clare ^a,b   Capuano, Corinne ^c   Palmer, Kevin ^c   Kelly, Paul M ^b   Durrheim, David N ^a,d  

^a HUNTER NEW ENGLAND POPULATION HEALTH   (Australia)

^b The Australian National University   (Australia)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIPARASITIC AGENT; DIETHYLCARBAMAZINE;

ARTICLE; CHROMATOGRAPHY; COOK ISLANDS; DEVELOPING COUNTRY; EPIDEMIOLOGICAL DATA; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; IMMUNOCHROMATOGRAPHY; INFECTION CONTROL; LYMPHATIC FILARIASIS; NIUE; PREVALENCE; SAMOA; TONGA; VANUATU; POLYNESIA;

ELEPHANTIASIS, FILARIAL; HEALTH SURVEYS; HUMANS; POLYNESIA; SAMOA; TONGA; VANUATU;

EID: 67649998349     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-92     Document Type: Article

References (17)

1. Michael E Bundy DA Grenfell BT Re-assessing the global prevalence and distribution of lymphatic filariasis Parasitology 1996, 112(Pt 4):409-428. 10.1017/S0031182000066646 8935952
2. World Health Organization WPR The PacELF Way: Towards the elimination of lymphatic filariasis from the Pacific, 1999-2005 Geneva, Switzerland: World Health Organization Publications; 2006.
3. Ottesen EA Duke BO Karam M Behbehani K Strategies and tools for the control/elimination of lymphatic filariasis Bull World Health Organ 1997, 75(6):491-503. 2487030 9509621
4. Krishna Kumari A Harichandrakumar KT Das LK Krishnamoorthy K Physical and psychosocial burden due to lymphatic filariasis as perceived by patients and medical experts Trop Med Int Health 2005, 10(6):567-573. 10.1111/j.1365-3156.2005.01426.x 15941420
5. Wijesinghe RS Wickremasinghe AR Ekanayake S Perera MS Physical disability and psychosocial impact due to chronic filarial lymphoedema in Sri Lanka Filaria J 2007, 6:4. 1851956 17391538 10.1186/1475-2883-6-4
6. Ottesen EA Lymphatic filariasis: Treatment, control and elimination Adv Parasitol 2006, 61:395-441. 10.1016/S0065-308X(05)61010-X 16735170
7. World Health Organization Preparing and Implementing a National Plan to Eliminate Lymphatic Filariasis WHO/CDS/CPE/CEE/200015. Geneva, Switzerland; 2000.
8. Weil GJ Lammie PJ Weiss N The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis Parasitol Today 1997, 13(10):401-404. 10.1016/S0169-4758(97)01130-7 15275155
9. Pani SP Hoti SL Elango A Yuvaraj J Lall R Ramaiah KD Evaluation of the ICT whole blood antigen card test to detect infection due to nocturnally periodic Wuchereria bancrofti in South India Trop Med Int Health 2000, 5(5):359-363. 10.1046/j.1365-3156.2000.00559.x 10886800
10. Clopper C Pearson E JavaStat: Exact Binomial and Poisson Confidence Intervals Pezzullo JC; 2005. 16240825
11. Michael E Malecela-Lazaro M Simonsen PE Pedersen EM Barker G Kumar A Kazura JW Mathematical modelling and the control of lymphatic filariasis Lancet 2004, 4:223-234.
12. Burkot TR Durrheim DN Melrose WD Speare R Ichimori K The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis Filaria J 2006, 5:10. 1560133 16914040 10.1186/1475-2883-5-10
13. Wynd S Carron J Selve B Leggat PA Melrose W Durrheim DN Qualitative analysis of the impact of a lymphatic filariasis elimination programme using mass drug administration on Misima Island, Papua New Guinea Filaria J 2007, 6:1. 1770912 17196113 10.1186/1475-2883-6-1
14. Babu BV Kar SK Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India Trop Med Int Health 2004, 9(6):702-709. 10.1111/j.1365-3156.2004.01247.x 15189460
15. Mathieu E Direny AN de Rochars MB Streit TG Addiss DG Lammie PJ Participation in three consecutive mass drug administrations in Leogane, Haiti Trop Med Int Health 2006, 11(6):862-868. 10.1111/ j.1365-3156.2006.01626.x 16772008
16. Gunawardena S Ismail M Bradley M Karunaweera N Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri Lanka Trans R Soc Trop Med Hyg 2007, 101(5):445-453. 10.1016/j.trstmh.2006.09.002 17125809
17. Wynd S Melrose WD Durrheim DN Carron J Gyapong M Understanding the community impact of lymphatic filariasis: A review of the sociocultural literature Bull World Health Organ 2007, 85(6):493-498. 2636343 17639248 10.2471/BLT.06.031047